Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

71729 1526457625HCLS_ECUADOR_Final.pdf
Energy Boardroom

Type your email in the box below to read this content NOW:

Ipsen: A Track Record of Excellence in Ireland

These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products.

French specialty-driven pharma outfit Ipsen has seen significant success in recent years, with global group sales totalling EUR 1.58 billion in 2016 - an 11.8 percent increase on the previous year -, 4,900 employees, operations in 115 countries, seven industrial sites and three major R&D centers. The group stands to grow even further with the recent acquisition of pancreatic cancer drug Onivyde® from Merrimack Pharmaceuticals, ambitious plans for further international expansion and the promise of a new global CEO in the near future.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: